Condition
STEMI clinical trials and research
As of November 12, 2026, Find a Trial lists 13 STEMI clinical trials that are recruiting, at sites in 17 countries (most in France (2), Italy (2), Australia (1)). By phase: Phase 3 (2), Phase 4 (1). There are also 3 NIH-funded research projects on STEMI, with $1.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 3NIH research projects
- 17Countries
Newest STEMI clinical trials
All recruiting trials (13)
-
Early single antiplatelet therapy after IVUS-guided PCI in ACS
This study tests whether stopping aspirin early and continuing a potent P2Y12 inhibitor alone is safe and effective after IVUS-guided PCI in people with acute coronary syndrome.
-
Drug-coated balloon treatment during emergency angioplasty for STEMI
This registry will try using drug-coated balloons instead of stents during emergency PCI for people with ST-elevation heart attacks to see how the procedure and patient outcomes compare.
-
Early intravenous landiolol to limit heart muscle damage after STEMI
This study tries early IV landiolol versus standard oral beta-blockers to see if it reduces the amount of heart muscle damage in adults with STEMI who undergo primary PCI.
-
Retinal OCTA to detect tiny blood vessel problems in people with MINOCA
This project will use a quick retinal OCTA scan to see if tiny blood vessel changes differ in people with MINOCA compared with heart attack patients who have blocked arteries and with healthy volunteers.
-
Long-term changes in left ventricular function after STEMI
We will test whether detailed heart imaging and blood tests can track long-term changes in heart structure and function in people who had a STEMI treated with primary PCI.
-
Targeted look at residual inflammation after a heart attack
This project will test whether the neutrophil-to-lymphocyte ratio (NLR) from the first routine blood draw can help predict risk of death in adults (18–85) after an acute coronary syndrome treated with PCI.
-
Assessing no-reflow in STEMI patients after tirofiban treatment
This study is testing if the drug tirofiban can help prevent no-reflow in patients with a severe heart attack who have had a procedure to open their blocked arteries.
-
Breisgau PHENO-HEART MI: Understanding Heart Attack Biology in Adults
This observational study in adults with STEMI or NSTEMI looks at the body’s immune response after a heart attack to understand how tissue damage and healing affect outcomes.
-
Using Dapagliflozin to Prevent Heart Changes After a Heart Attack
This study tests if the medication dapagliflozin can help prevent heart problems in people who have had a heart attack and have some heart weakness.
-
Registry to optimize management and outcomes for patients with acute myocardial infarction
This study is looking at how well different treatments work for patients who have had a heart attack and received a specific procedure called PCI, to see what helps them recover better.
-
Using Remote Ischaemic Conditioning to Improve Outcomes in STEMI Patients in Africa
This study is testing if a treatment called Remote Ischaemic Conditioning can help reduce deaths and heart failure in people with a severe heart attack in Africa.
-
Low-dose thrombolytic therapy for heart attack patients
This study is testing if a low dose of a clot-busting drug can help heart attack patients recover better after their treatment.
-
National observatory for interventional cardiology in France
This study is looking at how heart procedures are done in different hospitals in France to see how they can improve care for patients who have had heart tests or treatments.
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
AI screening to speed STEMI diagnosis in ED patients
A Stanford-led project uses artificial intelligence to quickly identify STEMI among ED patients with acute coronary syndrome to reduce treatment delays and improve outcomes.
-
Improving heart attack diagnosis using artificial intelligence
This study is working on using artificial intelligence to help emergency departments quickly and accurately identify heart attacks, especially for women and people of color who might not get diagnosed as fast, so everyone can receive the care they need within the first 10 minutes of arriving.
-
Improving emergency care for heart attack patients in rural areas
This study is working on a helpful mobile app for paramedics in rural areas to make sure they can give the best care to heart attack patients before they get to the hospital, aiming to speed up treatment and improve outcomes.
Related topics
Quick answers
How many STEMI clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 17 countries. The most sites are in France (2 trials), Italy (2 trials), Australia (1 trial), New Zealand (1 trial), Kenya (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.